Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Dermatological disorders medications are products that are topically applied to the skin. These products are used to treat skin diseases and can also be used to prevent certain skin diseases.
Dermatology diseases are one of the main causes of the global burden of non-fatal diseases, affecting millions of people. Aging, trauma, environmental and genetic factors can lead to the development of dermatology diseases.
The increased awareness of dermatology diseases, the high demand for rapid diagnosis, and the surge in the incidence of dermatology cancer and other dermatology diseases are factors that promote the growth of the dermatological disorders medications market. The increase in the number of elderly people, the increase in personal disposable income and the continuous research and development of dermatological disorders medications are also reasons for the growth of the market.
This report elaborates on the current development of the Dermatological Disorders Medications industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Mylan Pharmaceuticals
Galderma
Roche
GlaxoSmithKline
Barrier Therapeutics
Almirall
Pfizer
Sinclair Pharma
PharmaDerm
Bausch Health
By Type:
Over-The-Counter Drugs
Prescription Drugs
By Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Dermatological Disorders Medications Market Overview 2018-2029
-
1.1 China Dermatological Disorders Medications Industry Development Overview
-
1.2 China Dermatological Disorders Medications Industry Development History
-
1.3 China Dermatological Disorders Medications Industry Market Size (2018-2029)
-
1.4 China Dermatological Disorders Medications Market Analysis by Type from Production Side
-
1.4.1 China Dermatological Disorders Medications Production Volume, Production Value and Growth Rate of Over-The-Counter Drugs (2018-2029)
-
1.4.2 China Dermatological Disorders Medications Production Volume, Production Value and Growth Rate of Prescription Drugs (2018-2029)
-
1.5 China Dermatological Disorders Medications Market Analysis by Application from Consumption End
-
1.5.1 China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.5.3 China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.6 China Dermatological Disorders Medications Market Analysis by Region
-
1.6.1 North China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
Chapter 2 China Dermatological Disorders Medications Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Dermatological Disorders Medications Market Status and Competition at home and abroad in 2023
-
2.2.2 China Dermatological Disorders Medications Market Status and Competition Analysis in 2023
-
2.2.3 China Dermatological Disorders Medications Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Dermatological Disorders Medications Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Dermatological Disorders Medications Industry Development
Chapter 3 Dermatological Disorders MedicationsIndustry Chain Analysis
-
3.1 Dermatological Disorders Medications Industry Chain
-
3.2 Dermatological Disorders Medications Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Dermatological Disorders Medications Market
-
3.3 Dermatological Disorders Medications Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Dermatological Disorders Medications Market
Chapter 4 China Dermatological Disorders Medications Market, by Type
-
4.1 China Dermatological Disorders Medications Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Dermatological Disorders Medications Total Production Volume and Growth Rate from Production Side
-
4.5 China Dermatological Disorders Medications Production Volume and Growth Rate, by Type
-
4.5.1 China Dermatological Disorders Medications Production Volume and Growth Rate of Over-The-Counter Drugs
-
4.5.2 China Dermatological Disorders Medications Production Volume and Growth Rate of Prescription Drugs
Chapter 5 China Dermatological Disorders Medications Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Dermatological Disorders Medications Total Market Size and Growth Rate from Consumption End
-
5.5 China Dermatological Disorders Medications Market Size and Growth Rate, by Application
-
5.5.1 China Dermatological Disorders Medications Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Dermatological Disorders Medications Market Size and Growth Rate of Retail Pharmacies
-
5.5.3 China Dermatological Disorders Medications Market Size and Growth Rate of Online Pharmacies
Chapter 6 China Dermatological Disorders Medications Market, by Region
-
6.1 China Dermatological Disorders Medications Production Volume and Production Value, by Region
-
6.2 China Dermatological Disorders Medications Sales Volume and Sales Value, by Region
Chapter 7 North China Dermatological Disorders Medications Market Analysis
-
7.1 North China Dermatological Disorders Medications Market, by Type
-
7.2 North China Dermatological Disorders Medications Market, by Application
Chapter 8 Central China Dermatological Disorders Medications Market Analysis
-
8.1 Central China Dermatological Disorders Medications Market, by Type
-
8.2 Central China Dermatological Disorders Medications Market, by Application
Chapter 9 South China Dermatological Disorders Medications Market Analysis
-
9.1 South China Dermatological Disorders Medications Market, by Type
-
9.2 South China Dermatological Disorders Medications Market, by Application
Chapter 10 East China Dermatological Disorders Medications Market Analysis
-
10.1 East China Dermatological Disorders Medications Market, by Type
-
10.2 East China Dermatological Disorders Medications Market, by Application
Chapter 11 Northeast China Dermatological Disorders Medications Market Analysis
-
11.1 Northeast China Dermatological Disorders Medications Market, by Type
-
11.2 Northeast China Dermatological Disorders Medications Market, by Application
Chapter 12 Southwest China Dermatological Disorders Medications Market Analysis
-
12.1 Southwest China Dermatological Disorders Medications Market, by Type
-
12.2 Southwest China Dermatological Disorders Medications Market, by Application
Chapter 13 Northwest China Dermatological Disorders Medications Market Analysis
-
13.1 Northwest China Dermatological Disorders Medications Market, by Type
-
13.2 Northwest China Dermatological Disorders Medications Market, by Application
Chapter 14 Company Profiles
-
14.1 Mylan Pharmaceuticals
-
14.1.1 Mylan Pharmaceuticals Company Profile
-
14.1.2 Mylan Pharmaceuticals Dermatological Disorders Medications Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Galderma
-
14.2.1 Galderma Company Profile
-
14.2.2 Galderma Dermatological Disorders Medications Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Roche
-
14.3.1 Roche Company Profile
-
14.3.2 Roche Dermatological Disorders Medications Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline Dermatological Disorders Medications Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Barrier Therapeutics
-
14.5.1 Barrier Therapeutics Company Profile
-
14.5.2 Barrier Therapeutics Dermatological Disorders Medications Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Almirall
-
14.6.1 Almirall Company Profile
-
14.6.2 Almirall Dermatological Disorders Medications Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer
-
14.7.1 Pfizer Company Profile
-
14.7.2 Pfizer Dermatological Disorders Medications Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sinclair Pharma
-
14.8.1 Sinclair Pharma Company Profile
-
14.8.2 Sinclair Pharma Dermatological Disorders Medications Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 PharmaDerm
-
14.9.1 PharmaDerm Company Profile
-
14.9.2 PharmaDerm Dermatological Disorders Medications Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bausch Health
-
14.10.1 Bausch Health Company Profile
-
14.10.2 Bausch Health Dermatological Disorders Medications Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Dermatological Disorders Medications Industry Research Conclusions
-
15.2 Dermatological Disorders Medications Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Dermatological Disorders Medications Industry Market Size (2018-2029)
-
Figure China Dermatological Disorders Medications Production Volume, Production Value and Growth Rate of Over-The-Counter Drugs (2018-2029)
-
Figure China Dermatological Disorders Medications Production Volume, Production Value and Growth Rate of Prescription Drugs (2018-2029)
-
Figure China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure China Dermatological Disorders Medications Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure North China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure Central China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure South China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure East China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Dermatological Disorders Medications Market Size and Growth Rate from 2018-2029
-
Figure Dermatological Disorders Medications Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Dermatological Disorders Medications Market Share by Type in 2018
-
Figure China Dermatological Disorders Medications Market Share by Type in 2023
-
Figure China Dermatological Disorders Medications Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Dermatological Disorders Medications Production Volume and Growth Rate of Over-The-Counter Drugs (2018-2023)
-
Figure China Dermatological Disorders Medications Production Volume and Growth Rate of Prescription Drugs (2018-2023)
-
Figure China Dermatological Disorders Medications Market Share by Application in 2018
-
Figure China Dermatological Disorders Medications Market Share by Application in 2023
-
Figure China Dermatological Disorders Medications Total Market Size and Growth Rate from Consumption End
-
Figure China Dermatological Disorders Medications Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Dermatological Disorders Medications Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Figure China Dermatological Disorders Medications Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Table China Dermatological Disorders Medications Production Volume by Region (2018-2023)
-
Table China Dermatological Disorders Medications Production Volume Share by Region (2018-2023)
-
Figure China Dermatological Disorders Medications Production Volume Share by Region (2018-2023)
-
Table China Dermatological Disorders Medications Production Value by Region (2018-2023)
-
Table China Dermatological Disorders Medications Production Value Share by Region (2018-2023)
-
Figure China Dermatological Disorders Medications Production Value Share by Region (2018-2023)
-
Table China Dermatological Disorders Medications Sales Volume by Region (2018-2023)
-
Table China Dermatological Disorders Medications Sales Volume Share by Region (2018-2023)
-
Figure China Dermatological Disorders Medications Sales Volume Share by Region (2018-2023)
-
Table China Dermatological Disorders Medications Sales Value by Region (2018-2023)
-
Table China Dermatological Disorders Medications Sales Value Share by Region (2018-2023)
-
Figure China Dermatological Disorders Medications Sales Value Share by Region (2018-2023)
-
Table North China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table North China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure North China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table North China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table North China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure North China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table Central China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table Central China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure Central China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table Central China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table Central China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure Central China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table South China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table South China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure South China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table South China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table South China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure South China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table East China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table East China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure East China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table East China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table East China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure East China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table Northeast China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table Northeast China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure Northeast China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table Northeast China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table Northeast China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table Southwest China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table Southwest China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure Southwest China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table Southwest China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table Southwest China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table Northwest China Dermatological Disorders Medications Production Volume by Type (2018-2023)
-
Table Northwest China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Figure Northwest China Dermatological Disorders Medications Production Volume Share by Type (2018-2023)
-
Table Northwest China Dermatological Disorders Medications Sales Volume by Application (2018-2023)
-
Table Northwest China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Dermatological Disorders Medications Sales Volume Share by Application (2018-2023)
-
Table Mylan Pharmaceuticals Company Profile
-
Table Mylan Pharmaceuticals Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Galderma Company Profile
-
Table Galderma Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Barrier Therapeutics Company Profile
-
Table Barrier Therapeutics Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Almirall Company Profile
-
Table Almirall Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Sinclair Pharma Company Profile
-
Table Sinclair Pharma Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table PharmaDerm Company Profile
-
Table PharmaDerm Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
Table Bausch Health Company Profile
-
Table Bausch Health Dermatological Disorders Medications Revenue, Price and Gross (2018-2023)
-
